bupropion has been researched along with buprenorphine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Cleary, J; Macenski, MJ; Thompson, T | 1 |
Allen, JP; Litten, RZ | 1 |
Tyndale, R | 1 |
Klein, JW | 1 |
Ahmadi, J; Biuseh, M; Sahraian, A | 1 |
Bierut, LJ; Grucza, RA; Mintz, CM; Presnall, N; Xu, KY | 1 |
2 review(s) available for bupropion and buprenorphine
Article | Year |
---|---|
Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Bupropion; Forecasting; Humans; Methadyl Acetate; Naltrexone; Substance-Related Disorders; Taurine; Tobacco Use Disorder | 1999 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
1 trial(s) available for bupropion and buprenorphine
Article | Year |
---|---|
A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Bupropion; Central Nervous System Stimulants; Craving; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Iran; Male; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult | 2019 |
3 other study(ies) available for bupropion and buprenorphine
Article | Year |
---|---|
Effects on opioid-induced rate reductions by doxepin and bupropion.
Topics: Animals; Antidepressive Agents; Buprenorphine; Bupropion; Columbidae; Dose-Response Relationship, Drug; Doxepin; Drug Tolerance; Methadone; Propiophenones; Reaction Time; Reinforcement Schedule | 1990 |
Drug addiction: a critical problem calling for novel solutions.
Topics: Benzazepines; Buprenorphine; Bupropion; Chronic Disease; Financing, Government; Genetic Testing; Harm Reduction; Humans; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Prevalence; Privacy; Quinoxalines; Receptors, Nicotinic; Recurrence; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance-Related Disorders; Varenicline | 2008 |
Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis.
Topics: Analgesics, Opioid; Buprenorphine; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |